Editorial
Published on 29 Aug 2024
Editorial: Infectious diseases and cancer: convergence and divergence between bacteria, viruses and helminths
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2024.1471156
- 368 views
Type at least 3 characters
1,330 articles
Articles
Perspective
Published on 26 Aug 2024
Intratumoral injection and retention hold promise to improve cytokine therapies for cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2024.1456658
- 1,311 views
Review
Published on 26 Aug 2024
Advances in understanding the role of immune checkpoint LAG-3 in tumor immunity: a comprehensive review
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2024.1402837
- 879 views
Original Research
Published on 26 Aug 2024
The AST/ALT ratio predicts survival and improves oncological therapy decisions in patients with non-small cell lung cancer receiving immunotherapy with or without radiotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2024.1389804
- 769 views
Original Research
Published on 26 Aug 2024
Predicting radiotherapy efficacy and prognosis in tongue squamous cell carcinoma through an in-depth analysis of a radiosensitivity gene signature
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2024.1334747
- 719 views
Study Protocol
Published on 26 Aug 2024
iVAC-XS15-CLL01: personalized multi-peptide vaccination in combination with the TLR1/2 ligand XS15 in CLL patients undergoing BTK-inhibitor-based regimens
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2024.1441625
- 968 views
Original Research
Published on 23 Aug 2024
A prognostic nomogram for patients with HR+ mucinous breast carcinoma based on the SEER database and a Chinese cohort study
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2024.1444531
- 773 views
Original Research
Published on 20 Aug 2024
Efficacy of PD-1 or PD-L1 inhibitors for the therapy of cervical cancer with varying PD-L1 expression levels: a single-arm meta-analysis
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2024.1454372
- 592 views
Original Research
Published on 19 Aug 2024
Predictive value of peri-chemotherapy hematological parameters for febrile neutropenia in patients with cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2024.1380195
- 541 views
Case Report
Published on 16 Aug 2024
Etoposide, cisplatin, and sintilimab combined with anlotinib in successful treatment of adrenocortical carcinoma with lung metastasis: a case report
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2024.1403762
- 784 views
- 1 citation
Case Report
Published on 14 Aug 2024
Immune-related intestinal pseudo-obstruction caused by immune checkpoint inhibitors: case report
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2024.1415117
- 840 views
- 1 citation
Systematic Review
Published on 07 Aug 2024
Research hotspots and trend of glioblastoma immunotherapy: a bibliometric and visual analysis
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2024.1361530
- 1,606 views
Case Report
Published on 29 Jul 2024
Sequential severe immune-related adverse events induced by PD-1 inhibitor: a case report and literature review
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2024.1391698
- 937 views
- 1 citation
Original Research
Published on 24 Jul 2024
Efficacy of novel allogeneic cancer cells vaccine to treat colorectal cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2024.1427428
- 3,114 views
Case Report
Published on 23 Jul 2024
Case report: A sustained survival benefit of third-line immunotherapy for refractory thymic carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2024.1326006
- 724 views
Case Report
Published on 18 Jul 2024
Major response of a peritoneal mesothelioma to nivolumab and ipilimumab: a case report, molecular analysis and review of literature
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2024.1410322
- 1,788 views
- 1 citation